Xu Yang1,2, Ding Cao3, Xiumei Liang4, Jiannong Zhao1. 1. Department of Medical Imaging, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. 2. Department of Medical Imaging, the Fifth People's Hospital of Chongqing, Chongqing, 400016, China. 3. Department of Hepatobiliary Surgery, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. 4. Department of Medical Imaging, the Fifth People's Hospital of Chongqing, Chongqing, 400016, China. vitamin198305@126.com.
Abstract
PURPOSE: Several studies have examined the relationships between diffusion tensor imaging (DTI)-measured fractional anisotropy (FA) and the symptoms of schizophrenia, but results vary across the studies. The aim of this study was to carry out a meta-analysis of correlation coefficients reported by relevant studies to evaluate the correlative relationships between FA of various parts of the brain and schizophrenia symptomatic assessments. METHODS: Literature was searched in several electronic databases, and study selection was based on précised eligibility criteria. Correlation coefficients between FA of a part of the brain and schizophrenia symptom were first converted into Fisher's z-scores for meta-analyses, and then overall effect sizes were back transformed to correlation coefficients. RESULTS: Thirty-three studies (1121 schizophrenia patients; age 32.66 years [95% confidence interval (CI) 30.19, 35.13]; 65.95 % [57.63, 74.28] males) were included in this meta-analysis. Age was inversely associated with brain FA (z-scores [95% CI] -0.23 [-0.14, -0.32]; p ˂ 0.00001). Brain FA of various areas was inversely associated with negative symptoms of schizophrenia (z-score -0.30 [-0.23, -0.36]; p ˂ 0.00001) but was positively associated with positive symptoms of schizophrenia (z-score 0.16 [0.04, 0.27]; p = 0.007) and general psychopathology of schizophrenia (z-score 0.26 [0.15, 0.37]; p = 0.00001). CONCLUSION: Although, DTI-measured brain FA is found to be inversely associated with negative symptoms and positively associated with positive symptoms and general psychopathology of schizophrenia, the effect sizes of these correlations are low and may not be clinically significant. Moreover, brain FA was also negatively associated with age of patients.
PURPOSE: Several studies have examined the relationships between diffusion tensor imaging (DTI)-measured fractional anisotropy (FA) and the symptoms of schizophrenia, but results vary across the studies. The aim of this study was to carry out a meta-analysis of correlation coefficients reported by relevant studies to evaluate the correlative relationships between FA of various parts of the brain and schizophrenia symptomatic assessments. METHODS: Literature was searched in several electronic databases, and study selection was based on précised eligibility criteria. Correlation coefficients between FA of a part of the brain and schizophrenia symptom were first converted into Fisher's z-scores for meta-analyses, and then overall effect sizes were back transformed to correlation coefficients. RESULTS: Thirty-three studies (1121 schizophreniapatients; age 32.66 years [95% confidence interval (CI) 30.19, 35.13]; 65.95 % [57.63, 74.28] males) were included in this meta-analysis. Age was inversely associated with brain FA (z-scores [95% CI] -0.23 [-0.14, -0.32]; p ˂ 0.00001). Brain FA of various areas was inversely associated with negative symptoms of schizophrenia (z-score -0.30 [-0.23, -0.36]; p ˂ 0.00001) but was positively associated with positive symptoms of schizophrenia (z-score 0.16 [0.04, 0.27]; p = 0.007) and general psychopathology of schizophrenia (z-score 0.26 [0.15, 0.37]; p = 0.00001). CONCLUSION: Although, DTI-measured brain FA is found to be inversely associated with negative symptoms and positively associated with positive symptoms and general psychopathology of schizophrenia, the effect sizes of these correlations are low and may not be clinically significant. Moreover, brain FA was also negatively associated with age of patients.
Authors: James J Levitt; Jorge L Alvarado; Paul G Nestor; Laura Rosow; Paula E Pelavin; Robert W McCarley; Marek Kubicki; Martha E Shenton Journal: Schizophr Res Date: 2011-10-20 Impact factor: 4.939
Authors: Konasale M Prasad; Catherine H Upton; Vishwajit L Nimgaonkar; Matcheri S Keshavan Journal: Schizophr Res Date: 2014-10-22 Impact factor: 4.939
Authors: Shivani Patel; Katie Mahon; Robin Wellington; Jianping Zhang; William Chaplin; Philip R Szeszko Journal: Schizophr Res Date: 2011-04-29 Impact factor: 4.939
Authors: David Luck; Lisa Buchy; Yvonne Czechowska; Michael Bodnar; G Bruce Pike; Jennifer S W Campbell; Amélie Achim; Ashok Malla; Ridha Joober; Martin Lepage Journal: J Psychiatr Res Date: 2010-08-12 Impact factor: 4.791
Authors: Thomas J Whitford; Marek Kubicki; Jason S Schneiderman; Lauren J O'Donnell; Rebecca King; Jorge L Alvarado; Usman Khan; Douglas Markant; Paul G Nestor; Margaret Niznikiewicz; Robert W McCarley; Carl-Fredrik Westin; Martha E Shenton Journal: Biol Psychiatry Date: 2010-05-21 Impact factor: 13.382
Authors: Heleen B M Boos; René C W Mandl; Neeltje E M van Haren; Wiepke Cahn; G Caroline M van Baal; René S Kahn; Hilleke E Hulshoff Pol Journal: Eur Neuropsychopharmacol Date: 2012-07-26 Impact factor: 4.600
Authors: Giuseppina Rametti; Carme Junqué; Carlos Falcón; Nuria Bargalló; Rosa Catalán; Rafael Penadés; Benjamín Garzón; Miguel Bernardo Journal: Psychiatry Res Date: 2009-02-13 Impact factor: 3.222
Authors: Li Yao; Su Lui; Yi Liao; Ming-Ying Du; Na Hu; Joy A Thomas; Qi-Yong Gong Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2013-05-03 Impact factor: 5.067
Authors: Joseph I Friedman; Cheuk Tang; David Carpenter; Monte Buchsbaum; James Schmeidler; Lauren Flanagan; Shana Golembo; Isabella Kanellopoulou; Johnny Ng; Patrick R Hof; Philip D Harvey; Nicholas D Tsopelas; Daniel Stewart; Kenneth L Davis Journal: Am J Psychiatry Date: 2008-06-16 Impact factor: 18.112
Authors: Daniel Bergé; Anna Mané; Tyler A Lesh; Miquel Bioque; Fe Barcones; Ana Maria Gonzalez-Pinto; Mara Parellada; Eduard Vieta; Josefina Castro-Fornieles; Roberto Rodriguez-Jimenez; Maria Paz García-Portilla; Judith Usall; Cameron S Carter; Bibiana Cabrera; Miguel Bernardo; Joost Janssen Journal: Schizophr Bull Date: 2020-07-08 Impact factor: 9.306
Authors: Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson Journal: World Psychiatry Date: 2020-06 Impact factor: 49.548
Authors: Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi Journal: Mol Psychiatry Date: 2021-01-22 Impact factor: 13.437
Authors: Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert Journal: World J Biol Psychiatry Date: 2020-07-09 Impact factor: 4.132
Authors: Hua Ye; Andrew Zalesky; Jinglei Lv; Samantha M Loi; Suheyla Cetin-Karayumak; Yogesh Rathi; Ye Tian; Christos Pantelis; Maria A Di Biase Journal: Schizophr Bull Date: 2021-07-08 Impact factor: 9.306
Authors: K M Prasad; J Gertler; S Tollefson; J A Wood; D Roalf; R C Gur; R E Gur; L Almasy; M F Pogue-Geile; V L Nimgaonkar Journal: Psychol Med Date: 2020-09-03 Impact factor: 10.592
Authors: Luis F S Castro-de-Araujo; Mathew Allin; Marco M Picchioni; Colm Mcdonald; Christos Pantelis; Richard A A Kanaan Journal: Schizophr Res Date: 2018-03-28 Impact factor: 4.939